| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 320 | 1.993 | 3.355 | 6.600 | 2.880 | 3.391 | 3.541 | 4.491 | 0 |
| Total Income - EUR | - | 320 | 1.993 | 3.355 | 6.600 | 4.300 | 3.958 | 3.541 | 4.491 | 0 |
| Total Expenses - EUR | - | 193 | 1.158 | 1.235 | 2.804 | 8.258 | 4.614 | 4.475 | 4.516 | 0 |
| Gross Profit/Loss - EUR | - | 126 | 835 | 2.120 | 3.796 | -3.958 | -656 | -934 | -25 | 0 |
| Net Profit/Loss - EUR | - | 117 | 775 | 2.020 | 3.598 | -4.038 | -755 | -1.037 | -25 | 0 |
| Employees | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Angeloomier Therapy S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 1.290 | 691 | 333 | 0 |
| Current Assets | - | 616 | 1.410 | 2.864 | 6.555 | 3.134 | 567 | 1.644 | 521 | 0 |
| Inventories | - | 0 | 0 | 24 | 0 | 301 | 537 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 118 | 0 |
| Cash | - | 616 | 1.410 | 2.841 | 6.555 | 2.833 | 30 | 1.644 | 403 | 0 |
| Shareholders Funds | - | 161 | 934 | 2.936 | 6.477 | 2.317 | 1.510 | 478 | 451 | 0 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 0 |
| Debts | - | 455 | 476 | 93 | 78 | 237 | 346 | 1.857 | 403 | 0 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 581 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Angeloomier Therapy S.r.l.